These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34629350)

  • 21. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 23. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Professional translational research: a new hybrid paradigm in early drug discovery.
    Nussbaumer P; Klebl B
    Future Med Chem; 2015; 7(14):1879-89. PubMed ID: 26420644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Academia-Industry Alliance: Recent Trend].
    Nakagawa A; Perl L; Lee J; Harada-Shoji N; Ota C; Shiga T; Sunami S; Niizuma K; Endo H; Harigae H; Tominaga T
    No Shinkei Geka; 2024 Jan; 52(1):213-225. PubMed ID: 38246689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 28. Innovation in Neurosurgery: Intellectual Property Strategy and Academia/Industrial Collaboration.
    Murayama Y
    Neurol Med Chir (Tokyo); 2016 Sep; 56(9):569-73. PubMed ID: 27298262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].
    Lyu ZJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):562-565. PubMed ID: 32521975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Industry's challenge to academia: changing the bench to bedside paradigm.
    Fluckiger SL
    Exp Biol Med (Maywood); 2006 Jul; 231(7):1257-61. PubMed ID: 16816131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Finding solutions for drug discovery in academia].
    Akimoto H
    Nihon Yakurigaku Zasshi; 2013 Dec; 142(6):297-303. PubMed ID: 24334929
    [No Abstract]   [Full Text] [Related]  

  • 33. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTS and hit finding in academia--from chemical genomics to drug discovery.
    Frearson JA; Collie IT
    Drug Discov Today; 2009 Dec; 14(23-24):1150-8. PubMed ID: 19793546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-intellectual effects of intellectual property.
    Lipinski CA
    Curr Opin Chem Biol; 2006 Aug; 10(4):380-3. PubMed ID: 16829159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Industry-government - academia cooperation center for medical innovation in Hokkaido University].
    Kodama KB; Arato T
    Nihon Yakurigaku Zasshi; 2015 Nov; 146(5):268-74. PubMed ID: 26558312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.